#generic drugs

[ follow ]
#supreme-court
Healthcare
fromwww.dw.com
1 week ago

Iran war squeezes India's pharma supply chain

India's pharmaceutical industry faces challenges due to rising oil prices and reliance on imported ingredients, impacting global generic drug supply.
#generic-drugs
Healthcare
from24/7 Wall St.
1 month ago

Clark Howard: $200 Walgreens Quote Became $22 at Cost Plus Drugs for This NC Man

Pharmacy pricing often misleads patients, with significant price differences between traditional pharmacies and cost-plus models like Mark Cuban's Cost Plus Drugs.
Intellectual property law
fromPatently-O
1 month ago

The Tinderbox: A Framework for Skinny-Label Inducement Before the Supreme Court

Generic manufacturers' decisions to market cheaper drugs with carved-out patented uses while promoting them as full equivalents raises questions about induced patent infringement liability in method-of-use patents.
Medicine
fromAxios
3 months ago

How TrumpRx drug prices compare to generic alternatives

TrumpRx offers branded-drug coupons that can lower branded prices but may list drugs with generics, risking steering consumers toward higher-cost branded options.
Intellectual property law
fromPatently-O
5 months ago

Label-Plus Liability: The Government Warns the Federal Circuit Misread Hatch-Waxman

The Solicitor General urges Supreme Court review to clarify that FDA-compliant skinny labels and basic commercial statements should not automatically constitute inducement of patent infringement.
fromLos Angeles Times
6 months ago

Cheap insulin pens will soon be available through state-backed deal, Newsom announces

ration insulin or go into debt to stay alive.
California
US politics
fromMedCity News
7 months ago

FDA Pilot Program Creates New Path for Faster Regulatory Review of Generic Drugs - MedCity News

FDA pilot program speeds regulatory review for generic drugs that use domestic APIs and are tested and manufactured entirely within the United States.
#mifepristone
Public health
fromFortune
7 months ago

Gates Foundation partners with Indian drugmakers to speed rollout of $40 HIV shot | Fortune

Generic lenacapavir at about $40 per patient annually will expand access to six-month HIV prevention injections for millions worldwide.
fromwww.aljazeera.com
8 months ago

WHO adds weight-loss, diabetes drugs to essential medicines list

The list, consisting of 523 medicines for adults and 374 for children, is a catalogue of the drugs the WHO believes should be available in all functioning health systems. The new editions of essential medicines lists mark a significant step toward expanding access to new medicines with proven clinical benefits and with high potential for global public health impact, said Yukiko Nakatani, WHO's assistant director-general for Health Systems, Access and Data.
Public health
Law
fromPatently-O
10 months ago

Corcept v. Teva Oral Argument: Infringement by Drug Label, Again

Federal Circuit's theory of infringement by drug label implicates generic drug companies for inducing infringement based on their product labels.
Intellectual property law
fromIPWatchdog.com | Patents & Intellectual Property Law
11 months ago

FTC Renews Campaign to Remove 'Junk' Inhaler and Device Patents from Orange Book Listings

FTC's warning letters may lead to extended litigation over patent listings.
The agency aims to improve access to generic drugs by challenging patents.
Targeted patents in the pharmaceutical sector are under scrutiny.
Efforts continue irrespective of longstanding industry calls for clearer guidelines.
fromTruthout
1 year ago

Tariffs on Pharmaceuticals May Be the Next Front in Trump's War on Public Health

One can't simply will the infrastructure and supply chains for the production of large amounts of medicines into existence overnight.
US politics
[ Load more ]